Ligand validation:9NSZ

Y33: (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid

Y33 is a Ligand Of Interest in 9NSZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9NSZ_Y33_A_301	64%	34%	0.116	0.915	1.34	1.28	2	3	0	0	100%	0.92
9NSY_Y33_A_301	1%	25%	0.322	0.507	1.46	1.58	2	5	0	0	100%	0.5
9NSX_Y33_A_301	1%	27%	0.348	0.512	1.4	1.56	2	1	0	0	100%	0.46
9D7A_Y33_B_301	98%	30%	0.054	0.975	1.28	1.51	2	4	0	0	100%	0.75
9D79_Y33_A_301	93%	27%	0.071	0.965	1.38	1.55	2	5	1	0	100%	0.63
9D7D_Y33_B_302	70%	37%	0.1	0.918	1.23	1.26	3	4	0	0	100%	0.86
9D7B_Y33_B_302	59%	29%	0.112	0.893	1.44	1.4	2	4	0	0	100%	0.86
8FAJ_Y33_A_301	53%	35%	0.136	0.898	1.47	1.09	3	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.